Managing a Biomedical Innovation I
Full course description
MBS1006 “Managing a Biomedical Innovation I” is part 1 of a longitudinal course which runs throughout the 2-year MBS program. In year 1, course activities are planned in three series, coinciding with the courses “Biomedical Challenges” (block 1), “Biomedical Approaches” (block 2), and “Designing Scientific Research” (block 5) respectively.
In block 1, the objective is to provide students with a structure for defining the unmet clinical need and the value proposition of a given innovation. Students are taught to clearly describe and articulate the ultimate clinical or practical problem and how their proposed innovation addresses the unmet need. When these two aspects are clearly described, the potential value of an innovation should logically follow. A structure for defining the clinical unmet need and articulating the value proposition for a given innovation is given based on the Value Proposition Canvas and the Business Model Canvas.
In block 2, we focus on aspects that are relevant and applicable to any biomedical innovation during its development and implementation: Intellectual Property, Regulatory Affairs and Quality Assurance, and Economic Viability Assessment. Contextual examples and the relevance of the subject matter will be illustrated based on panel discussions with UM/MUMC+ based biomedical startup companies. The companies discuss specific considerations related to the three topics mentioned above related to their innovations.
In block 5, students will learn to describe the relevance and societal impact of their research. Students will learn to narrowly define the target population, provide an estimate for the number of patients who are effected by the condition, and provide an estimate for the societal burden of the disease in terms of both costs and quality of life. The ultimate objective is to teach students how to accurately describe the desired societal changes that their research will contribute to.
- ILO1 – Identify user needs for the clinical problem
- ILO2 – Determine the market potential of a biomedical innovation
- ILO3 – Assess the IP landscape
- ILO4 – Apply relevant Regulations and Quality Assurance guidelines
- ILO5 – Identify and involve all stakeholders during the innovation development process